slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 27,181-27,210
Pages 1,418
Rows per page 30
Beat
27,181-27,210 of 42,534
27
The map focuses on Europe, despite the text mentioning USA, Australia, Asia, and Africa.ads-tec Energy | Investor Presentation Deck | 32 slides · ads-tec Energy
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
28
The slide serves as a visual proof-point for the partnership between Adstec and Porsche.ads-tec Energy | Investor Presentation Deck | 32 slides · ads-tec Energy
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
29
The slide features two photographs of the same charging infrastructure installation.ads-tec Energy | Investor Presentation Deck | 32 slides · ads-tec Energy
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
30
The slide serves as a visual portfolio of product deployments.ads-tec Energy | Investor Presentation Deck | 32 slides · ads-tec Energy
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
31
The slide showcases a specific product application (microgrid) with a visual of the containerized battery system and the internal battery racks.ads-tec Energy | Investor Presentation Deck | 32 slides · ads-tec Energy
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
32
The slide features two photographs: an aerial view of the facility and an interior view of the battery storage units.ads-tec Energy | Investor Presentation Deck | 32 slides · ads-tec Energy
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
10
The slide demonstrates the predictive power of the DRP biomarker by contrasting the entire study population (no benefit) with the DRP-selected subgroup (significant benefit).Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
11
Includes a stacked bar chart showing market growth projections for ovarian and pancreatic cancer.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
12
Mentions DRP (Drug Response Predictor) as a companion diagnostic to justify pricing premium.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
13
Includes a stacked bar chart showing market growth from 2019A to 2026E.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
14
The slide uses a box plot to show the distribution of DRP scores between clinical responders and non-responders, with a clear cutoff at 50.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
15
The table uses checkmarks and X marks to highlight the competitive advantage of Stenoparib.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
16
Includes clinical efficacy data (PFS) and commercial context.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
17
The slide uses a dot plot to show biomarker sensitivity distribution and a bar chart to compare ORR outcomes.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
18
The slide uses a timeline framework to visualize clinical trial phases and interim data milestones.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
19
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
20
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
21
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
22
The slide uses a timeline-like structure to organize milestones by drug program.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
23
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
25
The slide uses a numbered list format to structure the valuation critique.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · SolutionLoop · The Reveal1 hit
26
The chart highlights the gap between the market's historical valuation and the proposed acquisition price.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · SolutionLoop · The Reveal1 hit
27
Uses a combination of a bar chart for historical price targets and a bar chart for premium/discount analysis to frame the deal as undervalued.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · SolutionLoop · The Reveal1 hit
28
Uses a line chart to show historical valuation trends and a bar chart to compare valuation compression across peers.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution1 hit
29
Uses a stock price chart to anchor the argument that the company was trading at a level where a standard premium would have exceeded $100/share.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution1 hit
30
Uses a combination of TSR performance and deal premium benchmarking to expose the 'trough' valuation.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution1 hit
31
Uses a 'true undisturbed price' argument to challenge the fairness opinion's baseline.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution1 hit
32
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution1 hit
33
The slide uses a grid of pull-quotes to build consensus on the undervaluation of the target company.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution1 hit
34
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution1 hit